| Q35893839 | A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection. |
| Q92498648 | A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory |
| Q52683780 | Accuracy and reproducibility of fetal-fraction measurement using relative quantitation at polymorphic loci with microarray. |
| Q64120626 | An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21 |
| Q64055782 | An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study |
| Q33884196 | Assessment of circulating copy number variant detection for cancer screening |
| Q37691066 | Bioinformatics Approaches for Fetal DNA Fraction Estimation in Noninvasive Prenatal Testing |
| Q90736066 | Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer |
| Q52571244 | Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias. |
| Q37711864 | Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia |
| Q42393162 | Cell-free fetal DNA: the new tool in fetal medicine |
| Q30643919 | Copy-number variation and false positive prenatal aneuploidy screening results |
| Q39003554 | Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns |
| Q92516934 | Current status of spent embryo media research for preimplantation genetic testing |
| Q36668572 | DNA methylation screening and analysis. |
| Q34029044 | DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study |
| Q51810585 | Debates on fetal fraction measurement and DNA-based noninvasive prenatal screening: time for standardisation? |
| Q102152274 | Detection of cell-free foetal DNA fraction in female-foetus bearing pregnancies using X-chromosomal insertion/deletion polymorphisms examined by digital droplet PCR |
| Q51025463 | Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts. |
| Q91846514 | Development of a new methylation-based fetal fraction estimation assay using multiplex ddPCR |
| Q35900347 | Expanding diagnostic testing beyond cytogenetics: implications for birth defects research and surveillance |
| Q46724061 | Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening |
| Q35667120 | Fetal Aneuploidy Detection by Cell-Free DNA Sequencing for Multiple Pregnancies and Quality Issues with Vanishing Twins |
| Q35339140 | Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma |
| Q52725964 | Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening. |
| Q102061414 | High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening |
| Q34618332 | High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma |
| Q40434858 | Highly sensitive faecal DNA testing of TWIST1 methylation in combination with faecal immunochemical test for haemoglobin is a promising marker for detection of colorectal neoplasia |
| Q38262952 | Implementation of whole genome massively parallel sequencing for noninvasive prenatal testing in laboratories |
| Q92995881 | Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening |
| Q36787475 | Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? |
| Q38211988 | Introducing WISECONDOR for noninvasive prenatal diagnostics |
| Q34205793 | MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer |
| Q43524466 | Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies |
| Q47130174 | Measurement of fetal fraction in cell-free DNA from maternal plasma using a panel of insertion/deletion polymorphisms |
| Q33832718 | Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma |
| Q34301776 | Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples |
| Q82261782 | Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma |
| Q34192088 | Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience |
| Q46170290 | Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma |
| Q36048523 | Noninvasive whole-genome sequencing of a human fetus. |
| Q90095578 | Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma |
| Q92895469 | PREFACE: In silico pipeline for accurate cell-free fetal DNA fraction prediction |
| Q26746025 | Profiling genome-wide DNA methylation |
| Q35069908 | Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma |
| Q26991553 | Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease |
| Q33767643 | Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. |
| Q40053685 | The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction |
| Q38099617 | The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made |
| Q54708648 | The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. |
| Q50674465 | Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma. |
Search more.